8.British Thoracic Society guidelines for the management of community-acquired pneumonia in adults - 2004 update. Available at: www.brit-thoracic.org.uk.
9.Craven DE, Palladio R, McQuillen DP. Healthcare-associated pneumonia in adults : management principles to improve outcomes. Infect Dis North Am 2004; 18: 939-962.
10.Чучалин А.Г., Синопальников А.И., Стручунский Л.С. и др. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике. Клин Микроб Антимикроб Химотер 2006; 8: 54-86.
11.National Center for Health Statistics. Health, United States, 2006, with chartbook on trends in the health of Americans. Available at: www.cdc.gov/nchs/data/hus/hus06/pdf.
12.Woodhead M, Blasi F, Ewig S, et al., Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26: 1138-1180.
13.Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired pneumonia in Adults. Clin Infect Dis 2007; 44: S27-72.
14.Чучалин А.Г. Пульмонология. Белая книга. М., 2003.
15.Зубков М.Н., Стецюк О.У., Козлов Р.С., Страчунский Л.С. Этиология и микробиологическая диагностика внебольничных пневмоний. В кн.: Пневмония / Под ред. А.Г. Чучалина, А.И. Синопальникова, Н.Е. Чернеховской. - М.: Экономика и информатика, 2002, c. 9-48.
16.Lieberman D, Schlaeffer F, Boldur I, et al. Multiple pathoges in adults patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax 1996; 51: 179-184.
17.Козлов Р.С., Сивая О.В., Шпынев К.В., и др. Антибиотикорезистентность Streptococcus pneumoniae в России в 1999 - 2005 гг.: результаты многоцентровых проспективных исследований ПеГАС-I и ПеГАС-II. Клин Микроб Антимикроб Химиотер 2006; 8 :33-47.
18.Гогин Е.Е. Острые пневмонии. В кн.: Диагностика и лечение внутренних болезней: Руководство для врачей. В 3-х томах. Т.2. / Под ред Ф.И.Комарова, ред. М.: Медицина; 1991. с.30-59.
19.Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med 2003; 138: 109-118.
20.Синопальников А.И., Андреева И.В., Стецюк О.У. Пневмония в домах престарелых: современный взгляд на проблему. Клин Микроб Антимикроб Химиотер 2007; 9: 4-19.
21.Mandell L.A., Marrie T.J., Grossman R.F. et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000; 31: 383-421.
22.Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore). 1990;69:307-316.
23.Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
24. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 2003; 58: 377-382.
25.Martinez JA, Horcajada JP, Almela M, et al. Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Iinfect Dis 2003; 36: 389-395;
26.Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164: 637-644.
27.Синопальников А.И. Медленно разрешающаяся/неразрешающаяся внебольничная пневмония. В кн.: Пневмония / Под ред. А.Г. Чучалина, А.И. Синопальникова, Н.Е. Чернеховской. - М.: Экономика и информатика, 2002, c. 364-386.
28.Koivula I., Sten M., Makela P.H. Risk factors for pneumonia in the elderly. Am J Med 1994; 96: 313-320.
29.Hedlund J., Kalin M., Ortquist A. Recurrence of pneumonia in middle-aged and elderly after hospital-treated pneumonia: aetiology and predisposing conditions. Scand J Infect Dis 1997; 29: 387-392.
30.Jefferson TO, Demicheli V, Deeks JJ, et al. Amantadine and rimantadine for preventing and treating influenza A in adults. Cohrane Database Syst Rev 2002; 3: CD001169.
31.Jefferson TO, Demicheli V, Deeks JJ, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cohrane Database Syst Rev 2000; 2: CD001265.
32.Prevention and Control of Influenza. Recommendations of the Advisory Comittee on Immunization Practices (ACIP). MMWR April 20, 2001; Vol 50 ( RR4).
33.Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Mortal Morbid Wkly Rep 1997; 46(R-8): 1-24.
34.Чучалин А.Г., Синопальников А.И., Страчунский Л.С. и др. Нозокомиальная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике. Клин Микроб Антимикроб Химиотер 2005; 7: 4-31.
35.American Thoracic Society/Infectious Disease Society of America Guidelines of the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Resp Crit Care Med 2005; 171: 388-416.
36.Torres A, Valencia M, Sellares J. Nosocomial pneumonia. In: Encyclopedia of respiratory medicine. Eds: GJ Laurent, SD Shapiro. 2006, vol. 3, pp. 440-446. The Boulevard, Langford Lane, Kidlington, Oxford, UK.
37. Vincent JL. Ventilator-associated pneumonia. J Hosp Infect 2004; 57: 272-280.
38.Chastre J, Fagon J. Ventilator-associated pneumonia. Am J Resp Crit Care Med 2002; 165: 867-903.
39.Kollef MH. The importance of appropriate initial antibiotic therapy for hospital-acquired infections. Am J Med 2003; 115: 582-594.
40.Teasdale G, Jannett B, Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974 13;2(7872): 81-83.
41.Craven DE, De Rosa FG, Thornton D. Nosocomial pneumonia: emerging concepts in diagnosis, management, and prophylaxis. Curr Opin Crit Care 2002; 8: 421-429.
42.Baughman RP. Contemporary diagnosis and management of nosocomial pneumonias. Newtown, Pennsylvania: Handbooks in Health Care Co. 2005, 144 p.
43.Fabregas N, Ewig S, Torres A, et al. Clinacal diagnosis of ventilator-associated pneumonia revisited: comparative validation using immediate postmortem lung biopsies. Thorax 1999; 54: 867-873.
44.Fagon JL, Chastre J, Wolf M, et al. Invasive and noninvasive strategies for management of suspected ventilator-assiociated pneumonia. Ann Intern Med 2000; 132: 621-630.
45.Shorr AF, Sherner JH, Jackson WL, et al. Invasive approaches to diagnosis of ventilator-associated pneumonia: A meta-analysis. Crit Care Med 2005; 33: 46-53.
46.Pugin J, Auckenthaler R, Mili N, et al. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic blind broncho-alveolar lavage fluid. Am Rev Respir Dis 1991; 143: 1121-1129.
47.Kollef MH. Inadequate antimicrobial treatment: an important determination of outcome for hospitalized patients. Clin Infect Dis 2000; 31 (Suppl 4): S131-S138.
48.Niderman MS. Therapy of ventilator-associated pneumonia: What more can we do to use less antibiotics? Crit Care Med 2004; 32: 2344-2345.
49.Kollef MH. Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 2004; 32: 1396-1405.
50.A Guide to Infection Control in the Hospital. - 2nd ed. R Wenzel, T Brewer, J-P Butzler, editors. London: BC Decker Inc; 2002.
document:
$pr:
version: 01-2007.1
codepage: windows-1251
type: klinrek
id: kli14144307
: 07.3. ОСТРЫЙ АБСЦЕСС И ГАНГРЕНА ЛЕГКИХ
